Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States.

48Background: New drugs have become available for the treatment of metastatic prostate cancer (mPCa) during the last two decades. Here, we explored the clinical outcomes of de novo mPCa in 3 large ...